The latest analyst update on Anika Therapeutics centers on a higher price target, with modeled fair value moving from US$16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results